{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-21-041598","form_type":"8-K","ticker":"OM","cik":"0001484612","company_name":"Outset Medical, Inc.","filed_at":"2021-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.231725+00:00","generated_at":"2026-06-29T21:33:23.814492+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Outset Medical Q2 revenue up 115% to $25.2M; raises FY2021 guidance to $97-100M; names Nabeel Ahmed permanent CFO","bullets":["Revenue $25.2M, +115% YoY; product revenue $20.6M (+113%).","Gross margin improved to 4.2% from (40.6%) in prior year; product gross margin (7.0%) vs (57.7%).","Full-year 2021 revenue guidance raised to $97-100M from $92-97M, representing ~94-100% YoY growth.","Net loss of ($30.2M) or ($0.66) per share; non-GAAP net loss ($26.3M) or ($0.57) per share.","Nabeel Ahmed appointed permanent CFO effective July 30, 2021; salary increased to $385K and equity awards granted."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-21-041598","json":"https://secwatch.observer/filing/0001564590-21-041598.json","markdown":"https://secwatch.observer/filing/0001564590-21-041598.md","text":"https://secwatch.observer/filing/0001564590-21-041598.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484612/000156459021041598/0001564590-21-041598-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484612/000156459021041598/om-8k_20210730.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T21:33:23.814492+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5da806a2ff","claim":"Nabeel Ahmed was appointed as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer at Outset Medical, Inc..","evidence_excerpt":"On August 5, 2021, the Company announced the Board of Director’s approval of Mr. Ahmed’s transition to the permanent role of Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective July 30, 2021","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484612/000156459021041598/0001564590-21-041598-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}